Tags : Cobra Biologics

Biotech COVID-19

AstraZeneca Signs an Agreement with Cobra Biologics for Vaccines Against

Shots: AstraZeneca has signed a supply agreement with Cobra to provide GMP manufacture of the adenovirus vector-based COVID-19 vaccine candidate AZD1222, previously known as ChAdOx1 n-CoV-19 The companies collaborated to provide large scale manufacturing capacity of the AZD1222 vaccine. Cobra will be manufacturing the vaccine with first deliveries to be initiated in the UK in […]Read More